Clinical trials during pregnancy: what has been done Viviana DomínguezNuria RamosXavier Carné Review Article 11 November 2011 Pages: 455 - 458
Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy Luke E. GrzeskowiakAndrew L. GilbertJanna L. Morrison Review Article 13 November 2011 Pages: 459 - 467
Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review Juan LiHuiyan XuYanting Wen Review Article 16 November 2011 Pages: 469 - 477
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases P. ZarogoulidisN. PapanasK. Zarogoulidis Review Article 22 November 2011 Pages: 479 - 503
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience Rosa LerosePellegrino MustoAlfredo Tartarone Review Article 14 December 2011 Pages: 505 - 512
Role of p38 inhibition in cardiac ischemia/reperfusion injury Sarawut KumphuneSiriporn ChattipakornNipon Chattipakorn Review Article 29 December 2011 Pages: 513 - 524
Fluoroquinolone-induced liver injury: three new cases and a review of the literature Anna LicataClaudia RandazzoAntonio Craxì Review Article 14 January 2012 Pages: 525 - 532
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis Didier LebrecJaime BoschJasper Dingemanse Clinical Trial 20 November 2011 Pages: 533 - 541
The practical application of adaptive study design in early phase clinical trials: a retrospective analysis of time savings U. LorchK. BerelowitzJ. Taubel Clinical Trial 25 November 2011 Pages: 543 - 551
Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers G. ZadoyanD. RokittaU. Fuhr Clinical Trial Open access 21 December 2011 Pages: 553 - 560
Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis Shoude ZhangJia ChenBeibei Yang Clinical Trial 10 January 2012 Pages: 561 - 569
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation Hadi MolanaeiPeter StenvinkelLeif Bertilsson Special Article 09 December 2011 Pages: 571 - 577
Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes Seiichi HayatoSetsuo HasegawaAkihiro Ohnishi Pharmacodynamics 23 November 2011 Pages: 579 - 588
Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allografts Jürg ReichenFelix StickelJoan Korth-Bradley Pharmacodynamics 06 December 2011 Pages: 589 - 597
Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity—application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control Seunghoon HanJongtae LeeDong-Seok Yim Pharmacodynamics 30 December 2011 Pages: 599 - 605
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile Andreas ClemensJoanne van RynSebastian Härtter Pharmacodynamics Open access 18 January 2012 Pages: 607 - 616
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers Liat MlynarskyIdit Bejarano-AchacheYoseph Caraco Pharmacogenetics 10 November 2011 Pages: 617 - 627
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype–phenotype correlation in childhood Ersin GumusOzgur KaracaUmit Yasar Pharmacogenetics 11 November 2011 Pages: 629 - 636
CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population Pedro DoradoNatalia HerasAdrián LLerena Pharmacogenetics 15 November 2011 Pages: 637 - 644
Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics Meghan BrennanJ. Andrew WilliamsYingxue Cathy Liu Pharmacogenetics 15 December 2011 Pages: 645 - 655
Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients In-Wha KimYoo Jin MoonJung Mi Oh Pharmacogenetics 20 December 2011 Pages: 657 - 669
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation P. StrattaM. QuagliaC. Magnani Pharmacokinetics and Disposition 20 November 2011 Pages: 671 - 680
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations Tiina KaronenJouko LaitilaJanne T. Backman Pharmacokinetics and Disposition 23 November 2011 Pages: 681 - 688
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis Tanuja N. GengiahNicholas H. G. HolfordSalim S. Abdool Karim Pharmacokinetics and Disposition 23 November 2011 Pages: 689 - 695
Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects Sam RebelloSally ZhaoVenkateswar Jarugula Pharmacokinetics and Disposition 29 November 2011 Pages: 697 - 708
Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers Arun K. P.Venkata Subbaiah MedaSuresh B. Pharmacokinetics and Disposition 16 December 2011 Pages: 709 - 714
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir Michael W. JannVicky SpratlinChad VanDenBerg Pharmacokinetics and Disposition 16 December 2011 Pages: 715 - 721
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase Richard A. LarsonOphelia Q. P. YinPhilipp D. le Coutre Pharmacokinetics and Disposition 30 December 2011 Pages: 723 - 733
Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery Arantxazu IslaIñaki F. TrocónizAlicia Rodríguez Gascón Pharmacokinetics and Disposition 15 January 2012 Pages: 735 - 745
Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies Chun Shing KwokJessica Ka-Yan YeongYoon Kong Loke Pharmacoepidemiology and Prescription 15 November 2011 Pages: 747 - 755
Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis Philipp HoffmannFrieder Keller Pharmacoepidemiology and Prescription 17 November 2011 Pages: 757 - 765
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France Francois MontastrucAgnès SommetJean-Louis Montastruc Pharmacoepidemiology and Prescription 25 November 2011 Pages: 767 - 775
What’s in a label? An exploratory study of patient-centered drug instructions Laura J. SahmM. S. WolfS. Mc Carthy Pharmacoepidemiology and Prescription 30 November 2011 Pages: 777 - 782
Are commonly used psychoactive medications associated with lower urinary tract symptoms? Susan A. HallNancy N. MaserejianJohn B. McKinlay Pharmacoepidemiology and Prescription 04 December 2011 Pages: 783 - 791
Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study Véronique PizzoglioIsmaïl AhmedFrench Network of Pharmacovigilance Centres Pharmacoepidemiology and Prescription 06 December 2011 Pages: 793 - 799
Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study Asia N. RashedIan C. K. WongAntje Neubert Pharmacoepidemiology and Prescription 14 December 2011 Pages: 801 - 810
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? J. S. McLayD. StewartS. D. Heys Pharmacoepidemiology and Prescription 14 December 2011 Pages: 811 - 819
Drug-induced immune thrombocytopaenia: results from the Berlin Case–Control Surveillance Study Edeltraut GarbeFrank AndersohnHanife Kurtal Pharmacoepidemiology and Prescription 21 December 2011 Pages: 821 - 832
Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages Jolyce BourgeoisMonique M. ElseviersRobert R. Vander Stichele Pharmacoepidemiology and Prescription 22 December 2011 Pages: 833 - 844
Effects of personality on use of medications, alcohol, and cigarettes during pregnancy Eivind YstromMargarete E. VollrathHedvig Nordeng Pharmacoepidemiology and Prescription 22 December 2011 Pages: 845 - 851
Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine David M. WoodSusannah DaviesPaul I. Dargan Pharmacoepidemiology and Prescription 29 December 2011 Pages: 853 - 856
Do Parkinson’s disease patients disclose their adverse events spontaneously? Santiago Perez-LloretMaría Verónica ReyOlivier Rascol Pharmacoepidemiology and Prescription 29 December 2011 Pages: 857 - 865
Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study Sophie LochnerWilhelm KirchChristoph Schindler Pharmacoepidemiology and Prescription 30 December 2011 Pages: 867 - 875
EMA’s reflection on placebo does not reflect patients’ interests Vittorio Bertele’Rita BanziSilvio Garattini Point of View 02 December 2011 Pages: 877 - 879
Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma Rabindra Kumar JenaTrupti Rekha SwainManorama Swain Short Communication 30 November 2011 Pages: 881 - 884
Impact of age, gender and haplotypes of thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) genes on 6-mercaptopurine toxicity in children with acute lymphoblastic leukemia Patchva DorababuShaik Mohammad NaushadRaghunadharao Digumarti Letter to the Editors 14 December 2011 Pages: 885 - 886
Influence of age, sex, and haplotypes of thiopurine methyltransferase (TPMT) gene on 6- mercaptopurine toxicity in children with acute lymphoblastic leukemia Chakradhara Rao S. UppugunduriMarc Ansari Letter to the Editors 14 December 2011 Pages: 887 - 888
Cholesterol levels, statins, vitamin D, and associated risk of pneumonia Luca MascitelliWilliam B. GrantMark R. Goldstein Letter to the Editors 15 December 2011 Pages: 889 - 890
Interaction of flucloxacillin and quinidine W. J. ComuthJ. A. ComuthM. M. Malingré Letter to the Editors 28 December 2011 Pages: 891 - 893